First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis
- Resource Type
- Article
- Source
- In
Annals of Oncology August 2021 32(8):983-993 - Subject
Breast tumors - Language
- ISSN
- 0923-7534